Yasmin, Yaz Blood Clot Risk Updated on Warning Label
New warnings are being added about the increased risk of blood clots from Yaz and Yasmin, as well as all birth control pills that use the progestin drospirenone.
New warnings are being added about the increased risk of blood clots from Yaz and Yasmin, as well as all birth control pills that use the progestin drospirenone.
A Colorado man has filed a wrongful death lawsuit against Bayer, alleging that his wife died as a result of a stroke caused by Beyaz, a newer version of the…
A coalition of women’s health groups indicates that an FDA advisory committee may have recommended a recall of Yaz, Yasmin and related birth control pills if there had not been…
Bayer Healthcare reports that it has reached agreements to settle Yaz and Yasmin lawsuits brought by at least 70 women, but continues to face about 11,300 additional claims by women…
Bayer has filed a lawsuit against Watson Pharmaceuticals for trying to sell a generic version of Beyaz, an updated formulation of the controversial Yaz and Yasmin birth control pills.
The FDA is facing strong calls that it hold a new meeting to evaluate the safety of Yaz and Yasmin birth control pills, after issues involving a possible conflict of…
New questions are being raised about the validity of an FDA advisory committee that voted against recommending a Yaz and Yasmin recall last month.
The federal judge presiding over thousands of Yaz lawsuits and Yasmin lawsuits has delayed the first trial scheduled to begin next week, ordering the parties to meet with a special…
Reproductive and drug safety experts advised the FDA to add stronger label warnings of Yaz and Yasmin blood clot risks, but decided not to recommend a Yasmin and Yaz recall.
Some federal drug safety regulators indicate that the risk of blood clots from Yaz and Yasmin merit stronger warning labels than those found on other birth control pills.